The Valley Desk

ReviewPharmacoepidemiology and drug safetyPublished

Quantitative Benefit-Risk Assessment of Vaccination Against COVID-19: A Systematic Review

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Review
Venue
Pharmacoepidemiology and drug safety
Published
Subject terms
Humans; Vaccination; Risk Assessment; COVID-19; SARS-CoV-2; COVID-19 Vaccines; Quantitative Benefit–risk Assessment; Covid‐19
PubMed ID
39887891
PubMed Central ID
PMC11779546
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal